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Vacuolar (H+)-ATPase (V-ATPase) is a proton pump present in several compartments of eukaryotic cells to regulate physiological processes.
From biochemical studies it is known that the interaction between arginine 735 present in the seventh transmembrane (TM7) segment from subunit
a and specific glutamic acid residues in the subunit c assembly plays an essential role in proton translocation. To provide more detailed structural
information about this protein domain, a peptide resembling TM7 (denoted peptide MTM7) from Saccharomyces cerevisiae (yeast) V-ATPase was
synthesized and dissolved in two membrane-mimicking solvents: DMSO and SDS. For the first time the secondary structure of the putative TM7
segment from subunit a is obtained by the combined use of CD and NMR spectroscopy. SDS micelles reveal an α-helical conformation for
peptide MTM7 and in DMSO three α-helical regions are identified by 2D 1H-NMR. Based on these conformational findings a new structural
model is proposed for the putative TM7 in its natural environment. It is composed of 32 amino acid residues that span the membrane in an α-
helical conformation. It starts at the cytoplasmic side at residue T719 and ends at the luminal side at residue W751. Both the luminal and
cytoplasmatic regions of TM7 are stabilized by the neighboring hydrophobic transmembrane segments of subunit a and the subunit c assembly
from V-ATPase.
© 2006 Elsevier B.V. All rights reserved.Keywords: NMR; CD; V-ATPase subunit a; Peptide; Protein conformationAbbreviations: CD, Circular Dichroism; CSI, Chemical shift index; DMSO,
Dimethylsulfoxide; DSS, Sodium 2,2-dimethyl-2-silapentane-5-sulfonate; DTT,
Dithiothreitol; HMBC, Heteronuclear multiple bond correlation; HSQC,
Heteronuclear single quantum coherence; MTM7, Peptide mimicking the
seventh transmembrane segment of subunit a from V-ATPase; NMR, Nuclear
magnetic resonance; NOESY, Nuclear Overhauser enhanced spectroscopy;
SDS, Sodium dodecyl sulfate; TM, Transmembrane; TOCSY, Total correlation
spectroscopy; V-ATPase, Vacuolar proton-translocating adenosine triphospha-
tase; Vma, Vacuolar membrane ATPase encoding genes; Vph, Vacuolar
acidification encoding genes
⁎ Corresponding author. Tel.: +31 317482635; fax: +31 317 482 725.
E-mail address: marcus.hemminga@wur.nl (M.A. Hemminga).
URL: http://ntmf.mf.wau.nl/hemminga/ (M.A. Hemminga).
1 Present address: Departamento de Química Física y Instituto de Biotecno-
logía, Facultad de Ciencias, Universidad de Granada, Campus Fuentenueva s/n,
18071 Granada, Spain.
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.07.0141. Introduction
Vacuolar (H+)-ATPase (V-ATPase) is a large multi-protein
membrane-bound enzymatic complex present in almost all
types of eukaryotic cells [1–3]. It can be found both in the
intracellular and plasma membrane. It plays an important role in
endocytosis, intracellular targeting, in protein processing and
degradation. In plasma membranes the protein is involved in
renal acidification, pH homeostasis, and in bone resorption
[3,4]. The bone resorption process occurs in the membranes of
osteoclast cells and is an important step in the maintenance of
bone tissue [1,5]. The deregulation of osteoclasts can originate a
higher bone removal provoking osteoporosis. The drugs
available at the moment to reduce bone loss only have a
temporary effect, so new therapies are needed that work longer
Fig. 1. Partial sequence of subunit a from yeast V-ATPase, including the putative TM7 segment [3] (yellow box). Peptide MTM7 (shown in gray) includes residues
I717 up to M753. The functional amino acid residues in TM7 (H728, R735 and H743) are indicated in red. The numbering of the residues in peptide MTM7 is
according to the numbering of the entire subunit a [3].
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for V-ATPase is required to allow the control of bone removal.
The know-how to do so has been hampered due to the absence
of a high-resolution structure of the V-ATPase system. This
information together with dynamical studies of the system can
help to indicate targeting points that can be used to control V-
ATPase in human osteoclast cells.
The V-ATPase from yeast is the most studied member of the
V-ATPase family of enzymes due to the relative ease of its
biochemical manipulation. Via ATP hydrolysis, V-ATPase
translocates protons across the membrane against the electro-
chemical potential. ATP hydrolysis occurs in subunits A and B
in the cytoplasmic domain (V1), while proton translocation is
achieved by the transmembrane subunits in the membrane
domain (VO). The VO domain is composed of four subunits: a,
c, c′ and c″. The subunit c ensemble (c (Vma3p), c′ (Vma11p)
and c″ (Vma16p)) is part of the rotary motor, while subunit a
(Vph1p or Stv1p) [6] forms the stator.
One of the approaches to discover a way to control the
function of the enzyme aims at finding compounds that interact
with the transmembrane subunits involved in proton transloca-
tion. To enhance these studies high-resolution structures of the
transmembrane region are needed. The only high-resolution
structure of the VO domain known at this moment is from the
rotor of the gram-positive bacterium Enterococcus hirae [7].
Regarding subunit a only a low-resolution structure is available
together with biochemical information [8]. Disulphide-
mediated cross-linking and labelling experiments with subunit
a suggest that it is composed of nine putative transmembrane
helices and that it has a cytoplasmic domain of 400 residues [9].
The hydrophilic amino terminal part of subunit a is located in
the cytoplasm and its hydrophilic carboxyl terminal part is
located in the lumen [9,10]. It has also been reported that
residue R735 in the seventh putative transmembrane segment
(TM7) of subunit a plays a vital role in proton translocation
[10]. Mutation of R735 induces a total inhibition of proton
translocation, while mutations in other sections of the
membrane-spanning region have less inhibitory effects.
Subunits c, c′ and c″ of the rotor of yeast V-ATPase are
composed of four transmembrane segments and subunit c″
contains in addition a fifth cytoplasmic segment [3]. The
glutamic acid residues present in the fourth putative transmem-
brane segment of c and c′, and in the second transmembrane
putative segment of c″, are known to be essential for the proton
translocation capacity of the rotor [3,9,11].
In the most recent model that describes proton translocation
by V-ATPase an interaction between R735 (on TM7 of subunit
a) and the glutamic acids from the subunit c ensemble (E137 onTM4 of subunit c, E145 on TM4 of subunit c′, and E108 on
TM2 of subunit c″) is essential [10,12]. Proton translocation
happens via the integration of the proton in the subunit c
assembly. Subsequently the rotation of the motor delivers the
proton into the lumen [9].
In our work, we assume that the conformation of a putative
transmembrane peptide in a membrane-mimicking solvent is
related to the conformation in its native environment. It is
obvious that in this case interactions with the surrounding
transmembrane segments are lacking. However, the usefulness
and practicability of this approach is supported by several
structural studies on different membrane proteins: Ca2+–ATPase
[13], FO–F1–ATPase [14], potassium ion channel [15], divalent
metal transporter protein [16], bacteriorhodopsin [17,18],
rhodopsin [19], thrombomodulin [20], and G-protein coupled
receptor [21]. It is interesting to note that in some of these studies
the secondary structures obtained for the isolated transmem-
brane segments were indeed confirmed when the structure of the
complete protein was published [17,19,22]. Thus, the structure
of an isolated putative transmembrane segment contains
information on the natural conformational propensity of the
complete transmembrane proteic domain.
In this paper we report the conformational properties of the
putative seventh transmembrane segment (TM7) of subunit a
(Vph1) from the yeast Saccharomyces cerevisiae V-ATPase.
This transmembrane segment contains the essential R735. A
peptide that mimics the putative TM7 segment (denoted peptide
MTM7) is designed and synthesized (Fig. 1). Circular dichroism
spectroscopy (CD) reveals the secondary structure of peptide
MTM7 in SDS micelles and is used to characterize its thermal
stability. Two-dimensional (2D) 1H-NMR spectroscopy is
applied to probe the conformational properties of the peptide in
DMSO. These results provide information about the conforma-
tion and position of the putative seventh transmembrane segment
within the native hydrophobic environment of V-ATPase.
2. Materials and methods
2.1. Peptide design and synthesis
Based on the predicted localization of the seventh putative transmembrane
segment (TM7) from subunit a from yeast [3], a 37-residue peptide (MTM7)
was designed (Fig. 1). MTM7 includes the putative membrane-spanning section
V727 to M753 in which the activity-related amino acid residues (H729, R735
and H743) are located [3]. Residue R735 was placed in the center of the peptide
similar to as what would be expected for the corresponding membrane segment
in its natural environment [3]. The peptide also includes part of the cytoplasmic
and luminal putative turns. Throughout the paper the numbering of the amino
acid residues in peptide MTM7 will be the same as is used for the native subunit
a (Fig. 1).
Fig. 2. Far-UV CD spectra of peptide MTM7 in TFE and in SDS micelles
dissolved in deionized water (pH 6.0). MTM7 in TFE ( ), in 1:250 MTM7:
SDS (¯) and in 1:100 MTM7:SDS (▪▪▪). The final peptide concentration for all
the samples is 2.0 mM. The temperature is 20 °C.
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chemistry by Pepceuticals Ltd., Leicester, UK. The final purity was tested by
HPLC as well as mass spectrometry and was above 90%.
2.2. Solvents
Peptide MTM7 is a highly hydrophobic peptide with a poor solubility in
DPC micelles, TFE:water mixtures, and aqueous systems. To perform
conformational studies, two membrane-mimicking solvents commonly used in
literature were selected: SDS micelles (SDS from Merck, Darmstadt, Germany
and d25-SDS from Cambridge Isotopes), and d6-DMSO (Cambridge Isotopes)
[18–20,22–24]. The natural properties of each solvent determine which
spectroscopic technique can be used to study the conformational properties of
peptide MTM7, as is discussed below. SDS-PAGE electrophoresis gels of
peptide MTM7 dissolved in the solvents mentioned showed a single MTM7
band at 4.2 kDa, which indicates the absence of peptide aggregation.
2.3. Sample preparation
To prepare samples of peptide MTM7 solubilized in SDS for CD an NMR
experiments, the peptide was initially dissolved in TFA and dried under a stream
of nitrogen. A 3 mM solution was prepared in TFE resulting in a clear solution.
This peptide solution was mixed with a freshly made SDS solution at the desired
concentration. The final solution was clear. Deionized water was added to yield
a volume ratio of 16:1. The sample was mixed for 15 min and rapidly frozen
followed by drying under vacuum at −70°C. The dry samples were rehydrated
with deionized water (pH 6.0) resulting in clear solutions [25]. The final peptide
concentration was 2.0 mM. In all prepared SDS samples the concentration of
SDS was well above the cmc. For the NMR samples d25-SDS was used instead
of unlabelled SDS.
2.4. CD measurements
Circular dichroism spectroscopy is a useful technique to determine the
secondary structure of proteins and small peptides under various conditions [26–
28]. Here, this technique could only be used to study the conformational
behavior of peptide MTM7 in SDS micelles [18,20,22,24,27] because DMSO
strongly absorbs below 240 nm, thereby prohibiting the extraction of secondary
structure contents from CD spectra [27]. Sample preparation of peptide MTM7
in SDS micelles (peptide-to-SDS ratios were 1:100 and 1:250) was performed as
described above. For each experiment freshly prepared sample was used. The
concentration of peptide MTM7 was determined spectrophotometrically by
measuring the UV absorbance at 280 nm, using an extinction coefficient of
12,740 l mol−1 cm−1 [29]. For all the experiments the O.D. was below 0.5.
Far-UV CD spectra were recorded on a Jasco J-715 spectropolarimeter,
equipped with a Peltier thermal-controlled cuvette holder. The spectra were
recorded using a 0.01 cm path length quartz cuvette, from 260 to 190 nm, with a
1.0 nm step resolution and a response time of 0.25 s. The spectra were collected
and averaged over 25 scans. For the thermal stability experiments the ellipticity
at 222 nm was measured between 20 and 50 °C, with a temperature interval of
1.0 °C. At each temperature the sample was allowed to equilibrate for 5 min.
After reaching 50 °C the temperature was lowered again to 20 °C and a final
spectrum was acquired to check for reversibility. All spectra were baseline
corrected by using control samples without peptide.
The secondary structure content of peptide MTM7 was calculated using the
method of Chen [30] and the CD spectra deconvolution software CDNN [31].
The CDNN software calculates the secondary structure content of a protein by
comparison of its CD spectrum with a CD database of known protein structures.
The method of Chen [30] assumes that the ellipticity at 222 nm is exclusively
due to α-helix conformation. Thus the α-helix content of a protein {α} of n
residues is given by [30]:
af g ¼ ½h222½hmax222
1 k
n
  
 100; ð1Þ
where [θ]222 and [θ]222
max are the experimental and maximal (−39,500 deg cm2
dmol−1) values of the ellipticity at 222 nm, respectively. The wavelength
dependent constant k is 2.57 at 222 nm.2.5. NMR measurements
NMR samples were prepared in d25-SDS at different peptide-to-SDS ratios
(1:70, 1:100 and 1:250) as described above. For the NMR samples in DMSO,
peptideMTM7was dissolved in 500 μL of d6-DMSO at a concentration of about
2mM. Excess DTT (dithiothreitol) was added to the sample to avoid formation of
disulphide bridges and peptide aggregation [32]. As an internal standard 0.1 mM
DSSwas used. 1HNMR spectra were recorded at 750MHz on a Bruker DRX750
spectrometer. Natural abundance 2D 1H–13C HSQC and HMBC spectra were
recorded at 600 MHz on a Bruker spectrometer equipped with a cryoprobe. 2D
NOESY and TOCSY spectra were recorded as described elsewhere [33]. All
experiments were recorded at 30 °C. 2DNOESYexperiments were acquired with
mixing times of 100, 300 and 400 ms. 2D TOCSY experiments were acquired
with a mixing time of 75 ms. In case of all 2D-NMR experiments 2K data points
were collected in the t2 dimension and 1K data points were collected in the t1
dimension. The spectral width was 11 ppm for 1H, 80 ppm for 13C in the case of
2D 1H–13C HSQC and 160 ppm for 13C in case of 2D 1H–13C HMBC. The NMR
data were processed using XWINNMR from Bruker. Peak assignment and
spectral analysis were carried out using NMRView [34] and Sparky (Goddard,
T. D., and Kneller, D. G., University of California, San Francisco).
3. Results
3.1. Circular dichroism experiments
The far-UV CD spectra of peptide MTM7 in SDS micelles at
peptide-to-SDS ratios of 1:100 and 1:250 are shown in Fig. 2.
At both ratios the spectra show a maximum at 193 nm and two
minima at 208 and 222 nm, respectively, suggesting the
presence of helical structure in the peptide. The secondary
structure analysis of the CD spectra of peptide MTM7 is
compiled in Table 1. Both analysis methods are in good
agreement: 21–22% helical content for a peptide-to-SDS ratio
of 1:100 and 28–30% helical content for a peptide-to-SDS ratio
of 1:250, respectively. For peptide MTM7 dissolved in TFE, the
CDNN software indicates that is 100% α-helical, whereas the
method of Chen leads to a helical content of 106%. The latter
unrealistic percentage arises from the ellipticity value at 222 nm
(−45,244 deg cm2 dmol−1) and is explained in Discussion.
Both analysis methods show that MTM7 is in a full α-helical
conformation in TFE. Indeed, TFE is known to induce the
Table 1
Helical content of peptide MTM7 in SDS micelles as determined by Chen's
method [30] and CDNN [31]
Sample Chen's method (%) CDNN (%)
Peptide to SDS ratio 1:100 21 22
Peptide to SDS ratio 1:250 30 28
TFE 106 100
The standard error in the percentage is approximately ±4%. The temperature is
20 °C.
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proteins that have an inherent propensity to do so [24,35].
We carried out CD experiments in peptide–SDS solutions at
pH values from 2 to 12 in a 50 mM phosphate buffer. For both
peptide-to-SDS ratios of 1:100 and 1:250, no changes were
detected in the CD spectra (data not shown). We used high
concentrations of peptide MTM7 in DMSO and SDS samples
due to the technical demands to perform 2D NMR spectroscopy
on a non-isotope labelled peptide. To ensure that no concentra-
tion effects were taking place, CD spectra were recorded at a 10
times lower peptide concentration, however, the spectra did not
change.
To study the conformational stability of peptide MTM7, the
ellipticity is measured at 222 nm as a function of temperature up
to 50 °C (Fig. 3). At both peptide-to-SDS ratios the ellipticity
changes with temperature in a linear way, but no defined
unfolding transition is observed in the temperature range
studied. Upon cooling of peptide MTM7 in SDS back to
20 °C, the ellipticity at 222 nm returns to its original value (Fig.
3). Thus, the unfolding behavior of peptide MTM7 has a low
cooperativity and the conformational exchange between the
helical and unfolded conformations ofMTM7 is fully reversible.
3.2. NMR experiments in d6-DMSO
2D NMR spectra of peptide MTM7 in d25-SDS micelles
with peptide-to-SDS ratios of 1:70, 1:100 and 1:250 containFig. 3. Thermal stability experiment of peptide MTM7 solubilized in two
different peptide-to-SDS ratios (1:250 and 1:100). The points • and ▴
correspond to the CD measurements at 222 nm after cooling the sample to 20 °C.
Fig. 4. Th1HN–
1Hα (top),
1HN–
1HN (middle) and
1Hα–
1Hα (bottom) regions of
the 400 ms 2D NOESY spectrum of peptide MTM7 in d6-DMSO. Broadening
of cross peaks and resonance overlap limit the full assignment of all protons of
MTM7. Broadening and overlapping regions are marked with an asterisk.severely broadened cross peaks. As this effect is much less
severe in d6-DMSO, 2D
1H–1H TOCSY, NOESY and 1H–13C
natural abundance HSQC and HMBC spectra of peptide MTM7
are recorded in d6-DMSO. TOCSY, HSQC and HMBC spectra
are used to identify the different spin systems. The dNN(i, i+1)
NOE contacts observed in the NOESY spectra are used to
sequentially assign the spin systems of peptide MTM7 [36,37].
Even in d6-DMSO strong broadening and resonance overlap of
some 1HN–
1Hα contacts prevents unambiguous assignment of
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leucines, isoleucines and serines that have overlapping reso-
nances further complicates resonance assignments. Despite
these challenges 50% of the 1HN and
1Hα resonances are
assigned and are used for secondary structure analysis. The
chemical shifts obtained for 1HN,
1Hα and 13Cα are provided in
Table 2 and are deposited in the BioMagResbank under access
number BMRB-6878. This deposit also includes side chain
proton assignments, the 13C carbonyl, 13Cα and 13Cβ assign-
ments). The 13Cα chemical shift of 65.33 ppm found for A742 is
unusual (Table 2). Currently, we do not have an explanation for
this behavior.
The chemical shift index (CSI) method [38,39] is applied to
the 1Hα and 13Cα resonances and the results are shown in Fig.
5. The combination of consecutive 1Hα and 13Cα CSI values
indicates a propensity for an α-helix configuration for residues
T730-A738 and A742-Q745. The helical propensity informa-
tion for residues T730-A738 is limited due to the lack ofTable 2
1HN,
1Hα and
13Cα chemical shifts (in ppm) of peptide MTM7 dissolved in
d6-DMSO
Residue 1HN
1Hα
13Cα
717 I — — —
718 H — — —
719 T 8.07 4.23 60.00
720 I — — —
721 E — — —
722 F 8.08 4.47 62.06
723 C — — —
724 L — — —
725 N 7.90 4.59 56.32
726 C — — —
727 V 7.94 4.25 —
728 S — — —
729 H 8.14 4.65 61.64
730 T 7.81 4.17 —
731 A 8.17 4.28 56.80
732 S — — —
733 Y 7.90 4.50 61.96
734 L 7.73 — —
735 R 7.67 4.13 60.18
736 L 7.78 — —
737 W 7.94 4.45 60.18
738 A 8.06 4.29 56.80
739 L 7.94 — —
740 S — — —
741 L — — —
742 A 8.00 4.22 65.33
743 H 8.01 4.49 —
744 A 7.79 4.25 59.60
745 Q 8.20 4.21 66.60
746 L — — —
747 S — — —
748 S — — —
749 V 7.76 — —
750 L 8.12 4.54 57.90
751 W — — —
752 T 7.72 4.16 61.80
753 M — — —
A dash (—) indicates that no clear assignment was possible for this nucleus.
These results are also published in the BioMagResbank under access number
BMRB-6878.assignments of several 1Hα and 13Cα nuclei (residues L734,
L736 and L739 lack 1Hα and 13Cα assignments, and we were
not able to assign S732), so no strong evidence of α-helical
conformation can be concluded.
In Fig. 5 also the dαN(i, i+4) and dαN(i, i+3) NOE contacts
found for peptide MTM7 in DMSO are presented. These
contacts provide another source that indicates whether a peptide
segment has an α-helical conformation [36,37]. Combining the
NOE contacts with the CSI data leads to the identification of
three helical regions within MTM7: C723-A731, Y733-L739
and A742-V749 (Fig. 5).
4. Discussion
The putative seventh transmembrane segment of V-ATPase
subunit a contains an arginine residue (R735), which is known
to be essential for the function of V-ATPase. The exact role
played by R735 is however still a matter of discussion. An
interaction of R735 with the glutamic acid residue present in the
fourth transmembrane segment of the rotor subunits c, c′ and
the second transmembrane segment from subunit c″ has been
suggested [3,7]. Unfortunately, no high-resolution structure of
subunit a is available.
To overcome the typical problems associated with high-
resolution NMR studies of transmembrane proteins [40] we
designed peptide MTM7, which mimics the putative TM7
segment of subunit a, and investigated its conformational
characteristics. Taking into account that TM7 is located in a
proteic environment and is surrounded by other transmembrane
segments of subunit a and by the transmembrane sections of the
rotor subunits of V-ATPase, the peptide is expected to be highly
hydrophobic. Indeed, at NMR concentrations (1 to 2 mM)
peptide MTM7 is only soluble in the membrane-mimicking
solvents used in this paper: SDS micelles and DMSO. The 2D-
NMR spectra of peptide MTM7 in SDS micelles at different
ratios show a low signal-to-noise ratio and a severe peak
broadening, so no detailed conformational information could be
extracted by NMR. Therefore the SDS micelle system was used
to study the global conformation of the peptide by CD
spectroscopy. As NMR broadening effects are much less severe
in DMSO, this solvent was chosen to perform 2D-NMR
experiments. Unfortunately, DMSO has a too high UV cutoff to
permit the analysis of the peptide conformation by CD, so no
direct comparison can be made with the CD results obtained in
the SDS samples.
SDS is frequently used as a membrane mimetic environment
in NMR and CD studies on transmembrane peptides and
proteins [16,22,25,41–48]. CD spectroscopy in SDS micelles
(Fig. 2) shows that peptide MTM7 has a tendency to adopt an
α-helical conformation. The relatively low percentage of helical
content of peptides and proteins dissolved in SDS micelles has
been associated in literature to he use of SDS solutions below
its CMC [26]. However in our work the concentration of SDS is
always kept well above the typical CMC value of SDS. So for
both peptide:SDS ratios studied the differences can be
explained as follows. The hydrophobicity plot of peptide
MTM7 shows that it has a positive hydrophobic index
Fig. 5. Chemical shift index (■ - 1Hα CSI;□ - 13Cα CSI) [38,39] and NOE connectivities (dαN(i, i+4), dαN(i, i+3), dαN(i, i+2), and dNN(i, i+1)) of peptide MTM7
in d6-DMSO. Gray CSI values represent residues with a
1Hα CSI value indicative for a moderate tendency to form helices (Δδ(ppm) between −0.05 and −0.10). A
consecutive appearance of CSI values of −1 for 1Hα and +1 for 13Cα indicate a propensity for an α-helix conformation. Such a sequence is found for residues T730-
A738 and A742-Q745. For the residues T730-A738 the information is limited due to some missing assignments. Boxed residues have overlapping resonances and the
resonance assignments are ambiguous. The predicted α-helical regions ( ) are based on the combination of CSI data and NOE connectivities.
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Consequently, in a micellar environment like SDS, one would
expect that the detergent molecules cover the C-terminal part of
peptide MTM7 and that the N-terminal region of the peptide is
exposed to the aqueous phase. Such a behavior has been found
for other transmembrane peptides dissolved in similar micellar
systems [22,41]. However, based on the analyses of the CD data
peptide MTM7 has only a helical content between 21 and 30%
for peptide:SDS ratios of 1:100 and 1:250, respectively. This
low helical content can be explained in two ways: (1) the
presence of the R735 in the middle of the peptide sequence
might interfere with the peptide solubilization in the micelles
[19]; (2) peptide MTM7 is expected to be relatively flexible,
thereby rapidly undergoing multiple conformational states,
which means that longer helices would break into smaller ones
[28] and thus smaller ellipticity intensities would be obtained
[49]. The low helical content calculated is due to the relatively
low ellipticity values observed in the CD spectra, the other
features of which are typically α-helical. This low ellipticity
suggests that a relatively large fraction of the MTM7 molecules
in the micellar systems dynamically populates the unfolded
state (which has an almost zero CD intensity at 222 nm
[28,50]).
CD spectroscopy shows that peptide MTM7 adopts an α-
helical conformation in TFE (Table 1). The ellipticity minimum
at 222 nm is −45,244 deg cm2 dmol−1. In addition to this
anomalous value, the characteristic α-helical ellipticity max-
imum at 190 nm is red shifted to 193 nm. Both observations
support that MTM7 contains a longer stretch of helical residues
than commonly found in water-soluble globular proteins.
Traditional secondary structure analysis packages are based
on a comparison of the CD spectrum of interest with a library of
CD spectra of water-soluble proteins. However in case of
stretched transmembrane α-helical peptides it has been shown
that the ellipticity at 222 nm can be more negative than −39,500
deg cm2 dmol−1 and that the ellipticity maximum commonly
found at 190 nm now exhibits a red shift [50]. From these resultswe assume that peptide MTM7 in TFE adopts a full α-helical
structure possibly due to the natural propensity of the solvent
used to induce such a structure. Due to this possible solvent
artifact, we did not consider an NMR study of the peptide in
TFE.
The difference in helical content of peptide MTM7 in SDS
systems with peptide-to-SDS ratios of 1:100 and 1:250 can be
attributed to the rather low solubility of peptide MTM7 in SDS
micelles. At a peptide-to-SDS ratio of 1:100 the peptide is
surrounded by a relatively low number of SDS molecules that
cover the C-terminal part of MTM7 and provide a local
hydrophobic environment in which the C-terminal part of the
peptide dynamically populates an α-helical structure according
to its α-helix propensity. The other part of the peptide, which is
not surrounded by SDS molecules, is not in a favorable
stabilizing environment, so it will be unfolded giving rise to no
CD signal. Increasing the number of SDS molecules (1:250
sample) permits a new arrangement of the SDS molecules
around the peptide and a larger part of peptide MTM7 will be
covered by SDS [48]. As a result, a larger part of the peptide
dynamically populates the helical state and thus a stronger CD
signal at 222 nm is observed. Despite the low helical content
detected due to solvent constraints, this result suggests a natural
tendency of peptide MTM7 to adopt α-helical structure in the
domains stabilized by the SDS molecules. The thermal
unfolding results obtained for peptide MTM7 in SDS micelles
indicate that its unfolding is reversible and has a low
cooperativity (Fig. 3). Thus, MTM7 folding and unfolding is
not a one-step process, but involves an ensemble of different
intermediate structural states with similar free energies. The
population of these states changes gradually upon increasing the
temperature. Thus, the CD results in SDS micelles suggest that
the peptide has an inherent propensity to adopt such a secondary
structure in its highly hydrophobic natural environment in V-
ATPase. However, no conclusive evidence can be obtained
about which amino acid residues of MTM7 are involved in helix
formation.
Fig. 6. Hydrophobicity plot of the region in which TM7 of V-ATPase from yeast is located. The hydrophobicity is calculated using the Mpex software (Jaysinghe, S.,
Hristova, K. and White, S. H. (2000) http://blanco.biomol.uci.edu/mpex). The putative TM7 region is marked in yellow and peptide MTM7 is shown by a gray bar.
The three helical regions of peptide MTM7 as determined by NMR spectroscopy (Fig. 5) are depicted by . The arrow indicates amino acid residue T719.
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[51], experiments on different transmembrane proteins have
shown that structures obtained in DMSO and DMSO–water
mixtures accurately describe the structure of the protein or
peptide in its native environment [23,52–54]. As peptide
MTM7 is well soluble in DMSO in which it gives rise to
reasonable quality NMR spectra (Fig. 4), we use DMSO as a
solvent to study the conformation of peptide MTM7 by NMR
spectroscopy. The combination of the CSI profiles and the NOE
contacts indicates three α-helical regions in peptide MTM7:
C723-A731, Y733-L739 and A742-V749 (Fig. 5). For the
terminal sections of peptide MTM7 neither structural NOE
contacts, nor consistent CSI (T719, L750 and T752) values are
found. This is probably due to fraying of the terminal residues.
For the two regions between the three helical sections no
secondary structure information could be extracted from the
NMR data due to cross peak overlap and/or severe cross peak
broadening. Two CSI values are exceptional, the amino acid
residues V727 and H729 have CSI values that could indicate the
presence of a turn, or a helix bend around these residues.
However, the CSI values should only be taken as a strong
indicator of the helix propensity of the peptide; in fact, NOE
contacts are a more reliable indicator of an α-helical conforma-
tion and they predict that V727 and H729 reside in a helical
segment [36].
The hydrophobicity plot (Fig. 6) of the putative TM7
segment and of the adjacent putative loops, shows that the
putative cytoplasmic loop has negative hydrophobicity values
indicating that these residues are hydrophilic and located in the
water phase. Starting with residue T719 the hydrophobicity
values become positive for the first time, indicating that the
subsequent section of the putative TM7 segment could be
embedded in a hydrophobic environment. There are two small
amphipathic oscillations that could indicate the region of TM7
located at the interface between the hydrophobic protein
environment and the water phase cytoplasm. Nevertheless,from residue T719 to the luminal section, the average
hydrophobicity increases and stays at a high level. Thus,
instead of starting at V727 [9], the putative TM7 segment could
already start at T719. On the luminal side of TM7 the
hydrophobicity is high (Fig. 6) and this remains so in the
segment beyond the putative TM7. The model for subunit a [3]
indicates that TM7 connects to the next transmembrane segment
(TM8) via a putative loop composed of 8 residues (from T752 to
G760). Due to the high hydrophobicity of this loop, we assume
that it will be located in a hydrophobic proteic region. In such a
view, the TM7 tryptophan residue at position 751 could act as
an anchor [55] in the interface between the hydrophobic protein
environment and the water phase lumen.
The NMR results of peptide MTM7 in DMSO, combined
with the CD data of the peptide in SDS micelles, indicate that
the peptide has a high tendency to adopt an α-helical
conformation in a hydrophobic environment. Peptide MTM7
in SDS micelles shows a tendency to increase its helical
structure with an increase of SDS concentration (1:100 to
1:250). Nevertheless the SDS data show a lower helicity as
compared to the NMR results, but they support the observations
that peptide MTM7 has a propensity for α-helical conformation.
Thus in its natural hydrophobic environment (i.e., subunit a
from V-ATPase) the TM7 segment most likely is fully helical.
This finding is in agreement with recent work from the group of
Forgac [56]. In combination with the hydrophobic data
discussed, we propose that the putative TM7 in subunit a is a
32-residue helical segment that spans from T719 (cytoplasmic
side) to W751 (luminal side). However on basis of our data, it
cannot be excluded that the helical segment contains small non-
helical segments. The new putative TM7 segment is composed
of 32 amino acid residues and is within a hydrophobic part of
V-ATPase.
The proposed 32-residue helical seventh transmembrane
segment can now be aligned and compared with its neighboring
transmembrane subunits, especially with the transmembrane
Fig. 7. Schematic representation of peptide MTM7 embedded in its natural environment (i.e. V-ATPase). The light gray box represents subunit a. The TM7 segment of
subunit a runs from residue T719 up to W751 (see text). CD results show that TM7 is helical and this could be confirmed by NMR spectroscopy for the residues
colored light blue. For the residues colored white no resonance assignment are available due to cross peak broadening and resonance overlap. The dark gray box
represents the V-ATPase rotor and the yellow regions represent the membrane. Arginine residue 735 known to be involved in proton translocation is indicated in red.
The height of the light gray box is calculated based on the demonstrated helicity of the comprising residues and assuming a rise of 1.5 Å per residue along the helical
axis. The height of the rotor of yeast H+-V-ATPase is based on the X-ray structure of the rotor subunit of Na+-V-ATPase [7,57].
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32-residue helix spans approximately 49 Å and we aligned the
putative TM7 along the rotor subunit of V-ATPase (Fig. 7). TM7
needs to be in contact with the transmembrane segments present
in subunits c, c′ and c″. This structural proximity is required as it
forms the basis for the mechanism of proton translocation. This
translocation occurs between R735 and the glutamic residues
that are present in the subunit c assembly. The height of the rotor
in the three-dimensional structure of the rotor subunits from F1–
FO–ATPase from yeast [57] and Na
+-V-ATPase from Entero-
coccus hirae [7] is 58 and 68 Å, respectively. Besides the
transmembrane helical segments it also comprises the cytoplas-
mic and luminal-embedded sections of the transmembrane rotor.
The height of the rotor is thus larger than that of the proposed
TM7. However, if one focuses on the localization and the length
of the transmembrane sections of the rotor that interact with
TM7, as determined for F1–FO–ATPase and Na
+-V-ATPase,
some similarities are observed. The transmembrane segments
found for F1–FO–ATPase are composed of 30 or 40 amino acid
residues (depending on the segment involved) and are partially
embedded in the cytoplasm. The four transmembrane segments
present in the rotor of Na+-V-ATPase include 28 to 35 amino
acid residues and part of it is proposed to be embedded in the
cytoplasm. The proposed TM7 of V-ATPase studied here
comprises 32 amino acid residues (T719-W751), is helical and
aligned along the rotor subunits. The length of a fully α-helical
transmembrane section this long would be approximately 49 Å.
Assuming that R735 is located in the middle of the membrane
bilayer as it has to face the functionally important glutamic acid
residues of the rotor subunits, and taking into account a bilayer
thickness of 39 Å, TM7 extends into the cytoplasm with 9 of its
residues and as this region is helical it has a height of
approximately to 15 Å (Fig. 7). One side of this cytoplasmic
part of TM7 interacts with the rotor of V-ATPase and in
combination with the other transmembrane segments of subunit
a. A small section of TM7 is positioned in the lumen and alsointeracts with the rotor of V-ATPase (Fig. 7). From amechanistic
point of view the proposed transmembrane localization of TM7
supports the current model that describes the action of V-
ATPase. In this model, two hemi-channels emerge in which
proton translocation occurs and the putative TM7 is supposed to
be part of the cytoplasmic hemi-channel, where protons are
transported into the membrane region.
In this paper we present, for the first time, experimental
results that demonstrate that the seventh segment of subunit a
adopts an α-helical structure. Based on the conformational
results this segment adopts a more extended α-helical structure
than predicted. In the new topology, TM7 spans from the lumen
to the cytoplasm, where it is stabilized by a hydrophobic proteic
environment (Fig. 7). This new topology will help to better
understand the structure and function of subunit a in the H+-V-
ATPase enzyme.
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